These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23877086)

  • 21. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
    Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D
    Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urinary MicroRNAs as Potential Biomarkers of Bladder Cancer].
    Juráček J; Staník M; Peltanová B; Adamcová S; Doležel J; Fedorko M; Radová L; Slabý O
    Klin Onkol; 2018; 31(Supplementum1):155-157. PubMed ID: 29808692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection.
    Sasaki H; Yoshiike M; Nozawa S; Usuba W; Katsuoka Y; Aida K; Kitajima K; Kudo H; Hoshikawa M; Yoshioka Y; Kosaka N; Ochiya T; Chikaraishi T
    Clin Genitourin Cancer; 2016 Oct; 14(5):e493-e499. PubMed ID: 27157639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
    Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression profile of miRNAs in urine samples of bladder cancer patients.
    Nekoohesh L; Modarressi MH; Mowla SJ; Sadroddiny E; Etemadian M; Afsharpad M; Zolfaghari F; Barzegari M; Saffari M; Oskooei VK; Motevaseli E; Ghafouri-Fard S
    Biomark Med; 2018 Dec; 12(12):1311-1321. PubMed ID: 30507304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
    Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
    Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages.
    Descotes F; Dessen P; Bringuier PP; Decaussin M; Martin PM; Adams M; Villers A; Lechevallier E; Rebillard X; Rodriguez-Lafrasse C; Devonec M; Paparel P; Perrin P; Lazar V; Ruffion A
    BJU Int; 2014 Feb; 113(2):333-42. PubMed ID: 24053469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology.
    Yamada Y; Enokida H; Kojima S; Kawakami K; Chiyomaru T; Tatarano S; Yoshino H; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Cancer Sci; 2011 Mar; 102(3):522-9. PubMed ID: 21166959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A microRNA expression ratio defining the invasive phenotype in bladder tumors.
    Neely LA; Rieger-Christ KM; Neto BS; Eroshkin A; Garver J; Patel S; Phung NA; McLaughlin S; Libertino JA; Whitney D; Summerhayes IC
    Urol Oncol; 2010; 28(1):39-48. PubMed ID: 18799331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of microRNAs in the urine of patients with bladder cancer.
    Wang G; Chan ES; Kwan BC; Li PK; Yip SK; Szeto CC; Ng CF
    Clin Genitourin Cancer; 2012 Jun; 10(2):106-13. PubMed ID: 22386240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
    Friedrich MG; Weisenberger DJ; Cheng JC; Chandrasoma S; Siegmund KD; Gonzalgo ML; Toma MI; Huland H; Yoo C; Tsai YC; Nichols PW; Bochner BH; Jones PA; Liang G
    Clin Cancer Res; 2004 Nov; 10(22):7457-65. PubMed ID: 15569975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of bladder cancer by measuring CD44v6 expression in urine with real-time quantitative reverse transcription polymerase chain reaction.
    Hattori S; Kojima K; Minoshima K; Yamaha M; Horie M; Sawamura T; Kikuchi A; Deguchi T
    Urology; 2014 Jun; 83(6):1443.e9-15. PubMed ID: 24726313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.
    Yu J; Zhu T; Wang Z; Zhang H; Qian Z; Xu H; Gao B; Wang W; Gu L; Meng J; Wang J; Feng X; Li Y; Yao X; Zhu J
    Clin Cancer Res; 2007 Dec; 13(24):7296-304. PubMed ID: 18094410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers.
    Reinert T; Modin C; Castano FM; Lamy P; Wojdacz TK; Hansen LL; Wiuf C; Borre M; Dyrskjøt L; Orntoft TF
    Clin Cancer Res; 2011 Sep; 17(17):5582-92. PubMed ID: 21788354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine markers for detection and surveillance of non-muscle-invasive bladder cancer.
    Tilki D; Burger M; Dalbagni G; Grossman HB; Hakenberg OW; Palou J; Reich O; Rouprêt M; Shariat SF; Zlotta AR
    Eur Urol; 2011 Sep; 60(3):484-92. PubMed ID: 21684071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer.
    Dettlaff-Pokora A; Matuszewski M; Schlichtholz B
    Cancer Lett; 2005 May; 222(1):83-8. PubMed ID: 15837544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma.
    Mengual L; Burset M; Ribal MJ; Ars E; Marín-Aguilera M; Fernández M; Ingelmo-Torres M; Villavicencio H; Alcaraz A
    Clin Cancer Res; 2010 May; 16(9):2624-33. PubMed ID: 20406841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
    Guo B; Luo C; Xun C; Xie J; Wu X; Pu J
    Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.